Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/002210 stock hub

KRX/002210 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/002210is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

23.2B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/002210

In the news

Latest news · KRX/002210

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E10.1

P25 12P50 23.1P75 39.5

ROE2.9

P25 -17.1P50 0.7P75 8.5

ROIC3.8

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/002210 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

KRW

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	290
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7002210003
Last refreshed	2026-05-10
Market cap	KRW 23.2B
Price	KRW 973
Price currency	KRW
Rev Per Employee	270,489,992.59x
Sector	Healthcare
Sic	2834
Symbol	krx/002210
Website	https://dongsung-pharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.32%
FCF yield	-13.01%
P/B ratio	0.39x
P/E ratio	10.1x
P/S ratio	0.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.96%
EBITDA Margin	5.88%
Gross margin	57.64%
Gross Profit	KRW 45.2B
Gross Profit Growth	14.89%
Gross Profit Growth Q	-6.31%
Gross Profit Growth3 Y	4.88%
Net Income	KRW 1.7B
Net Income Growth Years	0%
Net Income Growth3 Y	-28.01%
Pretax Margin	2.23%
Profit Margin	2.17%
Profit Per Employee	KRW 5.9M
ROA	1.54
Roa5y	0.47
ROCE	4.21
ROE	2.85
Roe5y	0.76
ROIC	3.84
Roic5y	0.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-17.21%
Cagr15y	-1.34%
Cagr1y	-80.19%
Cagr20y	-0.44%
Cagr3y	-49.14%
Cagr5y	-40.51%
EPS Growth Years	0
EPS Growth3 Y	-27.69
Revenue Growth	13.99x
Revenue Growth Q	-0.97x
Revenue Growth Years	0x
Revenue Growth3 Y	7.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.62
Assets	KRW 124.6B
Cash	KRW 14.2B
Current Assets	KRW 84.6B
Current Liabilities	KRW 54.4B
Debt	KRW 34.9B
Debt EBITDA	KRW 7.57
Debt Equity	KRW 0.58
Debt FCF	KRW -11.55
Equity	KRW 60.2B
Interest Coverage	1.55
Liabilities	KRW 64.4B
Long Term Assets	KRW 40B
Long Term Liabilities	KRW 10B
Net Cash	KRW -20.7B
Net Cash By Market Cap	KRW -89.01
Net Debt EBITDA	KRW 4.49
Net Debt Equity	KRW 0.34
Tangible Book Value	KRW 59B
Tangible Book Value Per Share	KRW 3,343
WACC	4.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.47
Inventory Turnover	3.06
Net Working Capital	KRW 43.2B
Quick ratio	1.18
Working Capital	KRW 24.1B
Working Capital Turnover	KRW 2.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.59%
Dividend per share	KRW 0
Last Dividend	KRW 30
Payout Ratio	31.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-84.87%
1Y total return	-80.16%
200-day SMA	4,335.4
3Y total return	-86.85%
50-day SMA	3,759.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.54%
All Time High	49,300
All Time High Change	-98.03%
All Time High Date	2018-09-05
All Time Low	508.4
All Time Low Change	91.39%
All Time Low Date	2001-09-17
ATR	428.8
Beta	-0.15
Beta1y	-0.56
Beta2y	-0.36
Ch YTD	-78.98
High	1,410
High52	5,700
High52 Date	2024-07-31
High52ch	-82.93%
Low	973
Low52	973
Low52 Date	2025-06-24
Low52ch	0%
Ma50ch	-74.12%
Price vs 200-day SMA	-77.56%
RSI	18.53
RSI Monthly	13.29
RSI Weekly	16.11
Sharpe ratio	-1.58x
Sortino ratio	-1.57
Total Return	2.59%
Tr YTD	-78.98
Tr15y	-18.27%
Tr1m	-65%
Tr3m	-74.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 3.1B
Operating Income Growth	1,690.1
Operating Income Growth3 Y	12.4
Operating margin	3.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	1,055,210,000
Shares Insiders	3.24%
Shares Institutions	0.03%
Shares Out	23,884,525
Shares Qo Q	2.99%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -3B
Average Volume	952,877.8x
Bv Per Share	3,409.3
CAPEX	KRW -380.7M
Ch10y	-84.87
Ch15y	-23.08
Ch1m	-65
Ch1y	-80.16
Ch20y	-22.16
Ch3m	-74.66
Ch3y	-86.85
Ch5y	-92.54
Ch6m	-81.71
Change	-65%
Change From Open	-30
Close	2,780
Days Gap	-50
Depreciation Amortization	1,507,485,730
Dollar Volume	9,392,385,541
EBIT	KRW 3.1B
EBITDA	KRW 4.6B
EPS	KRW 96.34
F Score	4
FCF	KRW -3B
FCF Per Share	KRW -127
Financing CF	-145,402,200
Fiscal Year End	December
Founded	1,957
Graham Number	2718.4176
Graham Upside	179.4
Income Tax	KRW 47.5M
Investing CF	3,403,032,870
Is Primary Listing	1
Last Report Date	2013-06-30
Last Split Date	2008-12-18
Last Split Type	Forward
Lynch Fair Value	KRW 482
Lynch Upside	-50.5
Ma150	4,221.3
Ma150ch	-76.95%
Ma20	3,631.2
Ma20ch	-73.2%
Net CF	752,684,000
Open	1,390
Position In Range	0
Ppne	32,513,296,980
Price Date	2025-06-24
Price EBITDA	KRW 5.04
Ptbv Ratio	0.39
Relative Volume	10.13x
Revenue	78,442,097,850x
Tax By Revenue	0.06x
Tax Rate	2.72%
Tr20y	-8.48%
Tr6m	-81.71%
Volume	9,653,017
Z Score	1.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KRX/002210 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/002210 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/002210?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

+3.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/002210 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

18.5

Below 30: short-term oversold

Price vs 200-day MA

-77.6%

50/200-day relationship not available

Beta (5Y)

-0.15

Less volatile than the market

Sharpe ratio

-1.58

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/002210

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/002210 stock rating?

krx/002210 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/002210 analysis?

The full report lives at /stocks/krx/002210/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/002210?

The latest report frames krx/002210 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/002210 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.